Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.

Federal Circuit

Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.

413 F. App'x 279

Court of Appeals for the Federal Circuit·Decided March 21, 2011·No. No. 2011-1217·Published

Opinion

ON MOTION

ORDER

BRYSON, Circuit Judge.

Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Barr [280] Laboratories, Inc. (collectively Teva) move to stay proceedings in this case pending the court’s disposition in Therasense, Inc. v. Becton, Dickinson & Co., 2008-1511 et al. The appellees oppose.

Upon consideration thereof,

It Is Ordered That:

(1) The motion to stay proceedings is denied.

(2) Teva’s initial brief is due within 60 days from the date of filing of this order.

Free access — add to your briefcase to read the full text and ask questions with AI

ON MOTION

ORDER

BRYSON, Circuit Judge.

Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Barr [280] Laboratories, Inc. (collectively Teva) move to stay proceedings in this case pending the court’s disposition in Therasense, Inc. v. Becton, Dickinson & Co., 2008-1511 et al. The appellees oppose.

Upon consideration thereof,

It Is Ordered That:

(1) The motion to stay proceedings is denied.

(2) Teva’s initial brief is due within 60 days from the date of filing of this order.

Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc., 413 F. App'x 279 (Fed. Cir. 2011).

Pincite

413 F. App'x 279 (Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.